📢Important Announcement
Our time on X with the #Screen4Care account is coming to an end, but the conversation continues on LinkedIn. Join us there—we’d love to stay connected! 🙏✨
🔗https://t.co/SAIfnz10aG
#RareDisease#NewbornScreening
Have a minute? ⏰Watch "60 Seconds with Alessandra Ferlini" to learn how our Scientific Coordinator is playing a key role in exploring the potential of next-generation sequencing and digital tools to improve outcomes for people living with rare diseases.👇
#Screen4Care@Roche
Today we hosted @Screen4Care’s Newborn Screening (NBS) Forum, brining together experts to explore the implications of genetic NBS.
As a core partner in #Screen4Care, we are ensuring that the patient voice is at the forefront of these vital discussions.⏬
https://t.co/VH5gJie59q
We are grateful to be part of a growing global community of researchers actively exploring the potential of newborn screening and digital tools to improve outcomes for children living with a rare disease . All signs suggest that our community is on the right track! 🙏
2/2
✨ Thanks to @ICoNSeqOrg for hosting a fantastic conference in New York last week and inviting Alessandra Ferlini, Scientific Coordinator at #Screen4Care, to share a poster presentation with important updates on our consortium.
#ICoNS24
1/2
✨ What a great time we had at #AOMCJMS2024 in Nara, Japan!
🔬 Our Sci Coordinator Alessandra Ferlini was honoured to speak on genetic diagnosis of neuromuscular diseases, exploring #Screen4Care’s mission to advance #GenomicMedicine. 🧬
Thanks to @one333 for the opportunity! 🙏
We are committed to contributing to #NBS programme expansions that bring benefits while addressing challenges, such as impacts on treatment access, psychological well-being, and family dynamics.
See you next year for more awareness on #NewbornScreening!
3/3
And that's a wrap for #NewbornScreeningAwarenessMonth 2024!
🌍 Did you know that newborn screening varies from country to country? National programmes currently screen for different numbers of rare conditions, as shown in the picture below. 🔍
1/3
#Screen4Facts#2024NBS#NBS
Thanks to recent and ongoing scientific and technological advancements, discussions are underway to expand #NBS programmes globally. At #Screen4Care, we believe in the importance of advancing research in newborn screening.
2/3
🧬 Did you know that 84% of #RareBarometer survey respondents support newborn screening for rare diseases to help parents make informed decisions and prepare for the future, even when treatments are not yet available?
1/3
#2024NBS#Screen4Care
👶 NBS can offer more than a faster diagnosis. 🩺 It can provide timely info for family planning, helping parents make informed decisions. It can connect families to economic & psych support, special ed, and physical therapy, all essential for effective childcare.
2/3
🧩Did you know 6% of parents of children w/ rare diseases would have preferred not to receive a diagnosis at birth? Anxiety, stigma and fear drive this choice.
❤️We understand these fears but we believe knowledge empowers & #NBS can help families from the start💪
#Screen4Facts
🩺 Calling all clinicians!
Contribute to developing a clinical decision-support model for rare diseases by taking our #survey, in collaboration with @bapemed, by Sept 30.
👉 https://t.co/u81wS3xxyu
Thank you for participating and sharing—your support matters! 🙏
#Screen4Care
No child should be deprived of early diagnosis and care that can improve or save lives.
Support a harmonised European approach to newborn screening.
Read the 11 Key Principles, available in 13 languages: https://t.co/b7re3nERPN
#NewbornScreening#RareDiseases#EqualCare
🧬 82% of parents of children with rare diseases wish for a birth diagnosis, according to the latest #RareBarometer survey. Early diagnosis can improve treatment and help children prepare for adulthood. 🌱
Let’s support #NBS for better futures. 🙏
#Screen4Care#Screen4Facts
🧬 September is Newborn Screening Awareness Month and we’re all in! This year we’re focusing on providing soon-to-be parents with key insights on #RareDisease screening. Stay tuned!🌟
#Screen4Facts#Screen4Care
Early genetic checks being developed by researchers with EU and industry funding will accelerate treatments for illnesses that affect millions of people in Europe.
Read more ➡️ https://t.co/0D7bEgSFYO
#ResearchImpactEU#HorizonMagazine